The DOI matches its Crossref record; 50 of the 55 references it cites were found in a registry or an index.
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers
Abstract
Objectives Ovarian carcinoma cells form multicellular aggregates, or spheroids, in the peritoneal cavity of patients with advanced disease. The current paradigm that ascites spheroids are non-adhesive leaves their contribution to ovarian carcinoma dissemination undefined. Here, spheroids obtained from ovarian carcinoma patients' ascites were characterized for their ability to adhere to molecules encountered in the peritoneal cavity, with the goal of establishing their potential to contribute to ovarian cancer spread.Methods Spheroids were recovered from the ascites fluid of 11 patients with stage III or stage IV ovarian carcinoma. Adhesion assays to extracellular matrix (ECM) proteins and human mesothelial cell monolayers were performed for each of the ascites spheroid samples. Subsequently, inhibition assays were performed to identify the cell receptors involved.Results Most ascites samples adhered moderately to fibronectin and type I collagen, with reduced adhesion to type IV collagen and laminin. Monoclonal antibodies against the beta1 integrin subunit partially inhibited this adhesion. Ascites spheroids also adhered to hyaluronan. Additionally, spheroids adhered to live, but not fixed, human mesothelial cell monolayers, and this adhesion was partially mediated by beta1 integrins.Conclusions The cellular content of the ascites fluid has often been considered non-adhesive, but our findings are the first to suggest that patient-derived ascites spheroids can adhere to mesothelial extracellular matrix via beta1 integrins, indicating that spheroids should not be ignored in the dissemination of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OVCAR-5 spheroids plated on a collagen-I coating, were observed to readily disaggregate with increasing collagen concentration, compared to laminin or collagen-IV coatings, thus highlighting its properties as a promoter of cancer cell adhesion and invasion (Burleson et al., 2004).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Burleson et al., 2004
Citations
Cites
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Cannistra, S. (1993) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 957
Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas 2
Sutherland, R. M., McCredie, J. A., & Inch, W. R. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/46.1.113 · Cited by 585
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Hardwick, C., Hoare, K., Owens, R. J., Hohn, H.-P., Höök, M., Moore, D. H., Cripps, V., Austen, L., Nance, D., & Turley, E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.6.1343 · Cited by 403
Isolation, culture and characterization of human peritoneal mesothelial cells
Stylianou, E., Jenner, L. A., Davies, M., Coles, G. A., & Williams, J. D. (1990) · Kidney International · doi:10.1038/ki.1990.150 · Cited by 389
Cannistra, S. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292108 · Cited by 294
Effects of intercellular contact on repair of radiation damage
Durand, R. E., & Sutherland, R. M. (1972) · Experimental Cell Research · doi:10.1016/0014-4827(72)90265-0 · Cited by 287
Flagged first, then by citations
5 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 271
Ning, Y., Zeineldin, R., Liu, Y., Rosenberg, M. J., Stack, M. S., & Hudson, L. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0407 · Cited by 49
In vitro three‐dimensional modelling of human ovarian surface epithelial cells
Lawrenson, K., Benjamin, E. O., Turmaine, M., Jacobs, I. J., Gayther, S. A., & Dafou, D. (2009) · Cell Proliferation · doi:10.1111/j.1365-2184.2009.00604.x · Cited by 48
Vašíčková, K., Horak, P., Ešner, M., Souček, K., Pils, D., Anees, M., Tomasich, E., Dráfi, F., Sedláková, V., Hampl, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29502 · Cited by 48
LKB1 and cancer: The dual role of metabolic regulation
Li, T., & Zhu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110872 · Cited by 47
Asem, M., Young, A., Oyama, C., Zerda, A. C. D. L., Liu, Y., Ravosa, M. J., Gupta, V. G., Jewell, A., Khabele, D., & Stack, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68639-2 · Cited by 48
An Overview of Concepts for Cancer Stem Cells
Chen, S.-Y., Huang, Y.-C., Liu, S., Tsai, F., Shyu, W., & Lin, S. (2010) · Cell Transplantation · doi:10.3727/096368910x532837 · Cited by 45
Medrano, M., Communal, L., Brown, K. R., Iwanicki, M., Normand, J., Paterson, J., Sircoulomb, F., Krzyzanowski, P. M., Novak, M., Doodnauth, S. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.028 · Cited by 45
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
Davidowitz, R. A., Iwanicki, M., & Brugge, J. S. (2012) · Journal of Visualized Experiments · doi:10.3791/3888 · Cited by 49
The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms
Naora, H. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000324 · Cited by 45
Three-dimensional modeling of ovarian cancer
White, E. A., Kenny, H. A., & Lengyel, E. R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.003 · Cited by 43
Jiang, L., Zhang, X., Du, P., & Zheng, J. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0140-1 · Cited by 42
Lee, H. R., Kim, D. W., Jones, V. O., Choi, Y., Ferry, V. E., Geller, M. A., & Azarin, S. M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001368 · Cited by 42
Ciucci, A., Buttarelli, M., Fagotti, A., Scambia, G., & Gallo, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04395-y · Cited by 44
Öncül, S., & Cho, M. S. (2023) · Cancers · doi:10.3390/cancers15041282 · Cited by 41
Boylan, K. L. M., Misemer, B. S., DeRycke, M. S., Andersen, J. D., Harrington, K. M., Kalloger, S. E., Gilks, C. B., Pambuccian, S. E., & Skubitz, A. P. N. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12021334 · Cited by 41
Transient commensal clonal interactions can drive tumor metastasis
Amara, S. N.-A., Kuiken, H. J., Selfors, L. M., Butler, T. M., Leung, M. L., Leung, C. T., Kuhn, E. P., Kolarova, T. R., Hage, C., Ganesh, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19584-1 · Cited by 40
Kennedy, A., Dong, H., Chen, D., & Chen, W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23871 · Cited by 41
Barbolina, M. V., Adley, B. P., Kelly, D. L., Shepard, J. A., Fought, A. J., Scholtens, D. M., Penzes, P., Shea, L. D., & Stack, M. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24347 · Cited by 39
Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
Salomonnson, E., Stacer, A. C., Ehrlich, A., Luker, K. E., & Luker, G. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051500 · Cited by 38
MENG, F., Sun, G., Zhong, M., Yu, Y., & BREWER, M. A. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1960 · Cited by 36
Ko, S. Y., & Naora, H. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-170 · Cited by 39
3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay
Marrella, A. (2020) · ALTEX · doi:10.14573/altex.2003131 · Cited by 36
An mDia2/ROCK Signaling Axis Regulates Invasive Egress from Epithelial Ovarian Cancer Spheroids
Pettee, K. M., Dvorak-Kornaus, K. M., Nestor‐Kalinoski, A. L., & Eisenmann, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090371 · Cited by 35
EGF-Receptor Regulation of Matrix Metalloproteinases in Epithelial Ovarian Carcinoma
Hudson, L. G., Moss, N. M., & Stack, M. S. (2009) · Future Oncology · doi:10.2217/fon.09.10 · Cited by 35
Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
Yang, J., & Stack, M. S. (2020) · Cancers · doi:10.3390/cancers12113469 · Cited by 35
In vitro modelling of the physiological and diseased female reproductive system
Stejskalová, A., Vankelecom, H. E. J., Sourouni, M., Ho, M. Y., Götte, M., & Almquist, B. D. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.032 · Cited by 36
Individual Cell-Based Model for In-Vitro Mesothelial Invasion of Ovarian Cancer
Giverso, C., Scianna, M., Preziosi, L., Buono, N. L., & Funaro, A. (2010) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20105109 · Cited by 35
Mesothelial Cells Facilitate Cancer Stem like properties in spheroids of ovarian cancer cells
Shishido, A., Mori, S., Yokoyama, Y., Hamada, Y., Minami, K., Qian, Y., Wang, J., Hirose, H., Wu, X., Kawaguchi, N., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6605 · Cited by 34
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates
Klymenko, Y., Wates, R. B., Weiss‐Bilka, H. E., Lombard, R., Liu, Y., Campbell, L., Kim, O. V., Wagner, D. R., Ravosa, M. J., & Stack, M. S. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034199 · Cited by 36
Tumor cell‑fibroblast heterotypic aggregates in�malignant ascites of patients with ovarian cancer
Han, Q., Huang, B., Huang, Z., Cai, J., Gong, L., Zhang, Y., Jiang, J., Dong, W., & Wang, Z. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4361 · Cited by 34
Davidson, B., Berner, A., Tropé, C. G., Wang, T., & Shih, I. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.12.009 · Cited by 34
Models of ovarian cancer metastasis: Murine models
Šale, S., & Oršulić, S. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.05.006 · Cited by 33
Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids
Desjardins, M., Xie, J., Main, H. G., Muralidhar, G. G., Suarez, J. S., Burdette, J. E., & Barbolina, M. V. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-70 · Cited by 32
Extracellular matrix mediates moruloid-blastuloid morphodynamics in malignant ovarian spheroids
Langthasa, J., Sarkar, P., Narayanan, S., Bhagat, R., Vadaparty, A., & Bhat, R. (2021) · Life Science Alliance · doi:10.26508/lsa.202000942 · Cited by 31
Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination
Yokoyama, Y., Sedgewick, G. J., & Ramakrishnan, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0172 · Cited by 32
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
Gharpure, K. M., Lara, O. D., Wen, Y., Pradeep, S., Lafargue, C. J., Ivan, C., Rupaimoole, R., Hu, W., Mangala, L. S., Wu, S. Y., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25344 · Cited by 31
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
Farsinejad, S., Cattabiani, T., Muranen, T. E., & Iwanicki, M. (2019) · Cancers · doi:10.3390/cancers11121957 · Cited by 30
Ojasalu, K., Brehm, C. U., Hartung, K., Nischak, M., Finkernagel, F., Rexin, P., Nist, A., Pavlakis, E., Stiewe, T., Jansen, J. M., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12749 · Cited by 31
Musrap, N., Tuccitto, A., Karagiannis, G. S., Saraon, P., Batruch, I., & Diamandis, E. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.639773 · Cited by 31
Feng, Y., Xiao, M., Zhang, Z., Cui, R., Jiang, X., Wang, S., Bai, H., Liu, C., & Zhang, Z. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00254-4 · Cited by 30
Llauradó, M., Majem, B., Castellví, J., Cabrera, S., Gil‐Moreno, A., Reventós, J., & Ruiz, A. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0449 · Cited by 30
Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells
Bruney, L., Liu, Y., Grisoli, A., Ravosa, M. J., & Stack, M. S. (2016) · Oncotarget · doi:10.18632/oncotarget.7880 · Cited by 29
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
Li, S., Ip, C. K. M., Tang, M. Y. H., Sy, S. K. H., Yung, S., Chan, T. M., Yang, M., Shum, H. C., & Wong, A. S. T. (2017) · Journal of Visualized Experiments · doi:10.3791/55337 · Cited by 29
Sambi, M., Haq, S., Samuel, V., Qorri, B., Haxho, F., Hill, K., Harless, W. W., & Szewczuk, M. R. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s130838 · Cited by 28
Singha, B., Laski, J., Valdés, Y. R., Liu, E., DiMattia, G. E., & Shepherd, T. G. (2020) · PubMed · Cited by 28
Ray, U., Roy, D., Jin, L., Thirusangu, P., Staub, J. K., Xiao, Y., Kalogera, E., Hendrickson, A. E. W., Cullen, G. D., Goergen, K. M., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01985-9 · Cited by 30
The multicellular signalling network of ovarian cancer metastases
Sommerfeld, L., Finkernagel, F., Jansen, J. M., Wagner, U. A. G., Nist, A., Stiewe, T., Müller‐Brüsselbach, S., Sokòl, A. M., Graumann, J., Reinartz, S., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.633 · Cited by 26
Loessner, D., Little, J. P., Pettet, G. J., & Hutmacher, D. W. (2013) · Journal of Cell Science · doi:10.1242/jcs.123836 · Cited by 27
Carduner, L., Agniel, R., Kellouche, S., Picot, C. R., Blanc‐Fournier, C., Leroy‐Dudal, J., & Carreiras, F. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.023 · Cited by 28
Celli, J. P. (2012) · Israel Journal of Chemistry · doi:10.1002/ijch.201200013 · Cited by 30
Dean, M., Jin, V., Bergsten, T. M., Austin, J. R., Lantvit, D. D., Russo, A., & Burdette, J. E. (2019) · Cancers · doi:10.3390/cancers11060884 · Cited by 28
Chemokine Receptors in Epithelial Ovarian Cancer
Muralidhar, G. G., & Barbolina, M. V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms15010361 · Cited by 27
Liu, Y., Yang, J., Shi, Z., Tan, X., Jin, N., O'Brien, C., Ott, C., Grisoli, A., Lee, E. B., Volk, K., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.024 · Cited by 26
Al‐Ayoubi, A. M., Tarcsafalvi, A., Zheng, H., Sakati, W. R., & Eblen, S. T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21889 · Cited by 27
Samardzija, C., Luwor, R. B., Volchek, M., Quinn, M. A., Findlay, J. K., & Ahmed, N. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0417-y · Cited by 27
Visco, Z. R., Sfakianos, G. P., Grenier, C., Boudreau, M.-H., Simpson, S., Rodriguez, I. V., Whitaker, R., Yao, D. Y., Berchuck, A., Murphy, S. K., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620873 · Cited by 16
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Reavis, H. D., Gysler, S. M., McKenney, G. B., Knarr, M., Lusk, H. J., Rawat, P., Rendulich, H. S., Mitchell, M. A., Berger, D. S., Moon, J. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170961 · Cited by 31
Akasov, R., Haq, S., Haxho, F., Samuel, V., Burov, S. V., Арнольдовна, М. Е., Neufeld, R. J., & Szewczuk, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.11868 · Cited by 26
An AFM-Based Nanomechanical Study of Ovarian Tissues with Pathological Conditions
Ansardamavandi, A., Tafazzoli‐Shadpour, M., Omidvar, R., & Nili, F. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254342 · Cited by 26
Wu, G., & Dickerson, E. B. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.03.003 · Cited by 26
Yoshida, Y., Kurokawa, T., Nishikawa, Y., Orisa, M., Kleinman, H. K., & Kotsuji, F. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.673 · Cited by 25
Yang, J., Kasberg, W., Celo, A., Liang, Z., Quispe, K., & Stack, M. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.800904 · Cited by 25
L-Glucose: Another Path to Cancer Cells
Ono, K., Takigawa, S., & Yamada, K. (2020) · Cancers · doi:10.3390/cancers12040850 · Cited by 27
Dehghani‐Ghobadi, Z., Hasani, S. S., Arefian, E., & Hossein, G. (2022) · Cells · doi:10.3390/cells11020237 · Cited by 26
Tzuman, Y. C., Sapoznik, S., Granot, D., Nevo, N., & Neeman, M. (2010) · Neoplasia · doi:10.1593/neo.91272 · Cited by 24
Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin
Kellouche, S., Fernandes, J., Leroy‐Dudal, J., Gallet, O., Dutoit, S., Poulain, L., & Carreiras, F. (2010) · Tumor Biology · doi:10.1007/s13277-010-0017-9 · Cited by 24
Goyeneche, A. A., Lisio, M. A., Fu, L., Srinivasan, R., Capuccino, J. V., Gao, Z., & Telleria, C. M. (2020) · Cancers · doi:10.3390/cancers12030699 · Cited by 23
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Bilandzic, M., & Stenvers, K. L. (2014) · Journal of Visualized Experiments · doi:10.3791/51655 · Cited by 22
Bilandzic, M., Wang, Y., Ahmed, N., Luwor, R. B., Zhu, H., Findlay, J. K., & Stenvers, K. L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.039 · Cited by 22
Suarez, J. S., Main, H. G., Muralidhar, G. G., Elfituri, O., Xu, H., Kajdacsy‐Balla, A., & Barbolina, M. V. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1205 · Cited by 21
In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy‐Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023) · Biomolecules · doi:10.3390/biom13010103 · Cited by 23
Terri, M., Sandoval, P., Bontempi, G., Montaldo, C., Tomero‐Sanz, H., de Turris, V., Trionfetti, F., Pascual‐Antón, L., Clares, I., Battistelli, C., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02930-8 · Cited by 20
Peters, P., Schryver, E. M., Lengyel, E. R., & Kenny, H. A. (2015) · Journal of Visualized Experiments · doi:10.3791/53541 · Cited by 25
Azimian, V., Hossein, G., Ebrahimi, M., & Dehghani‐Ghobadi, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.010 · Cited by 18
Therapeutic targets and new directions for antibodies developed for ovarian cancer
Bax, H. J., Josephs, D. H., Pellizzari, G., Spicer, J. F., Montes, A., & Karagiannis, S. N. (2016) · mAbs · doi:10.1080/19420862.2016.1219005 · Cited by 17
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems
Tomas, E. J., & Shepherd, T. G. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01145-x · Cited by 15
Haq, S., Samuel, V., Haxho, F., Akasov, R., Leko, M. V., Burov, S. V., Арнольдовна, М. Е., & Szewczuk, M. R. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s133563 · Cited by 16
Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells
Azimian, V., Dehghani‐Ghobadi, Z., Ebrahimi, M., Mirzazadeh, K., Nazarenko, I. A., & Hossein, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-85356-6 · Cited by 16
Hasanzadeh, A., Ebadati, A., Dastanpour, L., Aref, A. R., Zangabad, P. S., Kalbasi, A., Dai, X., Mehta, G., Ghasemi, A., Fatahi, Y., et al. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00102 · Cited by 16
Tarannum, N., Kumar, D., Surya, S. G., & Dramou, P. (2022) · Polymer Bulletin · doi:10.1007/s00289-022-04085-6 · Cited by 15
The role of exosome heterogeneity in epithelial ovarian cancer
Lee, A. H., Koh, I. L., & Dawson, M. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100040 · Cited by 15
Kawata, M., Kondo, J., Onuma, K., Ito, Y., Yokoi, T., Hamanishi, J., Mandai, M., Kimura, T., & Inoue, M. (2022) · Cancer Science · doi:10.1111/cas.15493 · Cited by 15
Baruah, U., Kumar, L., & Kataki, A. C. (2022) · Springer eBooks · doi:10.1007/978-981-19-5860-1_16 · Cited by 15
Musrap, N., Karagiannis, G. S., Saraon, P., Batruch, I., Smith, C. R., & Diamandis, E. P. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.03.042 · Cited by 14
Loessner, D., Kobel, S., Clements, J. A., Lütolf, M. P., & Hutmacher, D. W. (2013) · Microarrays · doi:10.3390/microarrays2030208 · Cited by 14
Klymenko, Y., Bos, B., Campbell, L., Loughran, E. A., Liu, Y., Yang, J., Kim, O. V., & Stack, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67565-7 · Cited by 14
Stadlmann, S., Feichtinger, H. G., Mikuz, G., Marth, C., Zeimet, A. G., Herold, M., Knabbe, C., & Offner, F. A. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000036 · Cited by 13
Zhou, L., Graves, M. L., MacDonald, G., Cipollone, J., Mueller, C. R., & Roskelley, C. D. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0395 · Cited by 13
Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis
Ho, C., Shih, D., Hsiao, C.-C., Huang, S., Chang, S.-F., & Cheng, W. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0722-7 · Cited by 13
Rio, D. D., Masi, I., Caprara, V., Spadaro, F., Ottavi, F., Strippoli, R., Sandoval, P., López‐Cabrera, M., de la Cuesta, R. S., Bagnato, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764375 · Cited by 12
Masi, I., Ottavi, F., Rio, D. D., Caprara, V., Vastarelli, C., Giannitelli, S. M., Fianco, G., Mozetic, P., Buttarelli, M., Ferrandina, G., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05612-7 · Cited by 12
Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners
Rizvi, I., Celli, J. P., Xu, F., Evans, C. L., Abu‐Yousif, A. O., Muzikansky, A., Elrington, S. A., Pogue, B. W., Finkelstein, D. M., Demirci, U., et al. (2011) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.875892 · Cited by 12
Balduit, A., Agostinis, C., Mangogna, A., Maggi, V., Zito, G., Romano, F., Romano, A., Ceccherini, R., Grassi, G., Bonin, S., et al. (2020) · Cancers · doi:10.3390/cancers12051175 · Cited by 12
Kerr, E. H., Frederick, P. J., Egger, M. E., Stockard, C. R., Sellers, J. C., Manna, D. L. D., Oelschlager, D. K., Amm, H. M., Eltoum, I.-E. A., Straughn, J. M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2878-9 · Cited by 12
Hassan, W., Chitcholtan, K., Sykes, P. H., & Garrill, A. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.013 · Cited by 10
Liu, Y., Xiao, H., Zeng, H., & Xiang, Y. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5705 · Cited by 10
Barbolina, M. V. (2022) · Cancers · doi:10.3390/cancers14184535 · Cited by 9
Ma, J., Salamoun, J. M., Wipf, P., Edwards, R. P., Houten, B. V., & Qian, W. (2017) · Oncotarget · doi:10.18632/oncotarget.23679 · Cited by 9
Calabrò, M. L., Lazzari, N., Rigotto, G., Tonello, M., & Sommariva, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239120 · Cited by 9
Grieco, J. P., Compton, S. L. E., Bano, N., Brookover, L., Nichenko, A. S., Drake, J. C., & Schmelz, E. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1043670 · Cited by 9
Metadata
- Authors
- Burleson, K. M., Casey, R. C., Skubitz, K. M., Pambuccian, S. E., Oegema, T. R., & Skubitz, A. P. N.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Skubitz, Amy P.N
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 93
- Issue
- 1
- Pages
- 170-181
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W1996604878
- Cited by
- 269
- References
- 55
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 14 · 2022: 11 · 2021: 24 · 2020: 23 · 2019: 12 · 2018: 13 · 2017: 17 · 2016: 13 · 2015: 13 · 2014: 21 · 2013: 18 · 2012: 11
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecologic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Minnesota
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ovarian carcinoma, ascites, tumor spheroids, cell adhesion, extracellular matrix, mesothelial cells, beta1 integrin, fibronectin, collagen, hyaluronic acid, cancer dissemination, peritoneal carcinomatosis
- MeSH terms
- Ascites, Cell Adhesion, Epithelium, Extracellular Matrix, Female, Humans, Hyaluronic Acid, Neoplasm Staging, Ovarian Neoplasms, Peritoneal Cavity, Tumor Cells, Cultured, Extracellular Matrix Proteins, Spheroids, Cellular, Integrin beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review